← Oscar Health, Inc.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $462.8m |
$1.8b
+297.30%
|
$61.0m
-96.68%
|
$5.9b
+9503.86%
|
$9.2b
+56.54%
|
$11.7b
+27.50%
|
$15.3b
+30.91%
|
|
| Selling, General and Administrative Expense | — | — | $1.3b | $1.4b | $1.8b | $2.0b | $2.1b | |
| Operating Income (Loss) | ($402.3m) |
($544.5m)
-35.35%
|
($589.9m)
-8.34%
|
($235.6m)
+60.06%
|
$57.3m
+124.30%
|
($396.4m)
-792.15%
|
— | |
| Other Operating Income (Expense), Net | — | — | $2.4m | — | — | — | — | |
| Interest Expense | $3.5m | $4.7m | $22.6m | $24.6m | $23.7m | $17.6m | $15.9m | |
| Net Investment Income | $8.0m | $10.2m | $31.3m | $155.4m | $185.7m | $202.9m | $248.2m | |
| Gain (Loss) on Investments | $1.2m | $212k | ($1.3m) | — | — | — | — | |
| Nonoperating Income (Expense) | — | — | — | ($7.1m) | ($105k) | ($23.3m) | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | ($405.8m) | ($570.6m) | ($610.1m) | ($267.3m) | $33.4m | ($437.3m) | $589.8m | |
| Current Income Tax Expense (Benefit) | $1.1m | $947k | ($358k) | $3.2m | $9.6m | $3.2m | $38.9m | |
| Income Tax Expense (Benefit) | $1.0m | $846k | ($523k) | $3.3m | $7.3m | $5.6m | $38.9m | |
| Net Income (Loss) Attributable to Parent | ($406.8m) |
($572.6m)
-40.75%
|
($606.3m)
-5.88%
|
($270.7m)
+55.35%
|
$25.4m
+109.39%
|
($443.2m)
-1842.49%
|
$558.2m
+225.96%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | ($414.2m) |
($572.6m)
-38.23%
|
($606.3m)
-5.88%
|
($270.6m)
+55.37%
|
$25.4m
+109.40%
|
($443.2m)
-1842.49%
|
$558.2m
+225.96%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | $0 | $1.2m | ($3.3m) | $134k | $689k | $248k | $558.2m | |
| Earnings Per Share, Basic | ($14.16) | ($3.20) | ($2.85) | ($1.22) | $0.11 | ($1.69) | $1.59 | |
| Earnings Per Share, Diluted | ($14.16) | ($3.20) | ($2.85) | ($1.22) | $0.10 | ($1.69) | $1.30 | |
| Weighted Average Number of Shares Outstanding, Basic | 29.3m | 179.0m | 212.5m | 221.7m | 240.4m | 262.4m | 285.8m | |
| Weighted Average Number of Shares Outstanding, Diluted | 29.3m | 179.0m | 212.5m | 221.7m | 265.9m | 262.4m | 292.9m | |
| Additional Financial Items | ||||||||
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims | $368.8m | $1.7b | $3.4b | $4.7b | $7.4b | $10.1b | — | |
| Policyholder Benefits and Claims Incurred, Net | $309.4m | $1.6b | $3.3b | $4.6b | $7.3b | $10.0b | — | |
| Benefits, Losses and Expenses | $865.1m | $2.4b | $4.6b | $6.1b | $9.1b | $12.1b | — | |
| Premiums Earned, Net | $455.0m | $1.8b | $3.9b | $5.7b | $9.0b | $11.5b | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.